norfloxacin has been researched along with Cholangitis in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen patients, 14 with an infection of the lower respiratory tract and two with cholangitis, were treated with pefloxacin 400 mg bid or tid." | 3.67 | Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units. ( Lauwers, S; Naessens, A; Pierard, D; Vincken, W, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanimura, H | 1 |
| Yoshida, K | 1 |
| Kobayashi, N | 1 |
| Uchiyama, K | 1 |
| Usui, Y | 1 |
| Nishimura, N | 1 |
| Ozawa, K | 1 |
| Kitamura, T | 1 |
| Izukura, K | 1 |
| Tamura, H | 1 |
| Lauwers, S | 1 |
| Vincken, W | 1 |
| Naessens, A | 1 |
| Pierard, D | 1 |
2 other studies available for norfloxacin and Cholangitis
| Article | Year |
|---|---|
[Chemotherapy of biliary tract infection (XXXII)--Excretion into bile, tissue level of the gallbladder and clinical effects of norfloxacin for biliary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Bile; Cholangitis; Cholecystitis; Female; Gallbladder; Humans; Male; | 1987 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Ch | 1986 |